June 23, 2025
Navigating PARP Inhibitor Reimbursement Policies
The recent reassessment of PARP inhibitor reimbursement by Zorginstituut Nederland marks a significant…
June 23, 2025
The recent reassessment of PARP inhibitor reimbursement by Zorginstituut Nederland marks a significant…
June 16, 2025
The National Institute for Health and Care Excellence (NICE) has approved Belantamab Mafodotin,…
June 9, 2025
The integration of AI in clinical trials offers significant potential to enhance efficiency,…
June 2, 2025
Non-communicable diseases (NCDs) pose a significant global health and economic challenge. As we…
May 26, 2025
Public-private partnerships are transforming the clinical trials landscape, particularly in Europe. These collaborations…
May 19, 2025
The recent announcement of Lars Fruergaard Jørgensen stepping down as CEO marks a…